BTTX — Better Therapeutics Share News
0.000.00%
HealthcareHighly SpeculativeMicro Cap
Brief: Better Therapeutics Reports Second Quarter 2022 Financial Results
Better Therapeutics Inc reports results for the quarter ended in June - Earnings Summary
Better Therapeutics Inc expected to post a loss of 45 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Honeywell International, Better Therapeutics, JAKKS Pacific
Better Therapeutics surges on additional data from diabetes trial
Brief: Better Therapeutics Completes Pivotal Trial Of BT-001 For Type 2 Diabetes
U.S. STOCKS ON THE MOVE-Grab Holdings Ltd, HeartCore Enterprises Inc, Twitter Inc
U.S. STOCKS ON THE MOVE-Omniq Corp, LumiraDx Ltd, Caterpillar Inc
U.S. STOCKS ON THE MOVE-J.Jill Inc, Roku Inc, DocuSign Inc
Brief: Better Therapeutics Announces Issuance Of U.S. Patent Covering Key Features Of Their Prescription Digital Therapeutics Platform
Better Therapeutics rises on first U.S. patent
Brief: Better Therapeutics Appoints Frank Karbe As Chief Executive Officer
U.S. RESEARCH ROUNDUP-Humacyte, Hyatt Hotels, Poseida Therapeutics
Better Therapeutics Inc reports results for the quarter ended in March - Earnings Summary
Brief: Better Therapeutics Reports First Quarter 2022 Financial Results
Better Therapeutics Inc expected to post a loss of 38 cents a share - Earnings Preview
Brief: Better Therapeutics Announces Key Milestones And Updates For Ongoing Studies Of Its Digital Therapeutics Approach For Cardiometabolic Diseases
Brief: Better Therapeutics Announces Q4 Results
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 10:09 AM